Companies / Kiora Pharmaceuticals, Inc.
Kiora Pharmaceuticals, Inc.
Nasdaq: KPRXCIK 1372514ENCINITAS, CA
Financials · FY2025
Ownership
4.4M shares outstanding · as of Aug 5, 2026
Ownership
| Insiders | 1.98% | 87,667 |
| 10%+ / strategic | 8.92% | 394,668 |
| Institutions | 15.11% | 668,381 |
| Public float | 73.99% | 3,273,671 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Strem Brian M.CEOPresident and CEO · Director | 1.37% | 60,692 |
Daniels Eric JosephFormerChief Development Officer | 0.72% | 31,741 |
| 0.61% | 26,975 | |
Hollander DavidDirector | — | — |
Parsons ErinDirector | — | — |
Shapiro AronDirector | — | — |
Stengone Carmine N.Director | — | — |
Tyle PraveenDirector | — | — |
Walters-Hoffert LisaDirector | — | — |
Institutional holders 20
View all →| Holder | Value | % of shares |
|---|---|---|
| $330.8K | 3.80% | |
| $258.4K | 2.96% | |
| $217.3K | 2.49% | |
| $209.1K | 2.40% | |
| $151.5K | 1.74% | |
| $92.3K | 1.08% | |
| $65.2K | 0.75% | |
| $44.1K | 0.51% | |
| $41.8K | 0.48% | |
| $32.9K | 0.28% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Strem Brian M. CEO | Other | Common Stock | $3.7K | -2K -3.04% | 60,692 1.37% of shares | low |
| Apr 1, 2026 | Tosca Melissa Executive | Other | Common Stock | $1.8K | -929 -3.33% | 26,975 0.61% of shares | low |
| Apr 1, 2026 | Daniels Eric Joseph Executive | Other | Common Stock | $1.8K | -929 -2.84% | 31,741 0.72% of shares | low |
| Mar 3, 2026 | Daniels Eric Joseph Executive | Other | Common Stock | $481 | -238 -0.90% | 26,137 0.59% of shares | low |
| Mar 3, 2026 | Strem Brian M. CEO | Other | Common Stock | $481 | -238 -0.52% | 45,865 1.04% of shares | low |
| Mar 6, 2026 | Daniels Eric Joseph Executive | Grant | Common Stock | $0 | +7K +25.00% | 32,670 0.74% of shares | low |
| Mar 6, 2026 | Strem Brian M. CEO | Grant | Common Stock | $0 | +17K +36.48% | 62,598 1.41% of shares | low |
| Mar 6, 2026 | Tosca Melissa Executive | Grant | Common Stock | $0 | +7K +30.57% | 27,904 0.63% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Orin Hirschman | Passive13G/A | — |
| Rosalind Advisors, Inc. | Passive13G/A | — |
| Nantahala Capital Partners Limited Partnership | Passive13G/A | — |
| Nantahala Capital Management, LLC | Passive13G/A | — |
| Alyeska Investment Group, L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| KPRX | — | 49721T507 |